Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 273754, 7 pages
http://dx.doi.org/10.1155/2014/273754
Clinical Study

Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration

1Sapienza University of Rome, Policlinico Umberto I Hospital, 155 Viale del Policlinico, 00161 Rome, Italy
2Casa di Cura Privata Villa Benedetta, 65 Circonvallazione Cornelia, 00165 Rome, Italy
3Casa di Cura Privata Villa Margherita, 48 Viale di Villa Massimo, 00161 Rome, Italy

Received 19 February 2014; Accepted 17 April 2014; Published 7 May 2014

Academic Editor: Toshiaki Kubota

Copyright © 2014 Magda Gharbiya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Brown, P. K. Kaiser, M. Michels et al., “Ranibizumab versus verteporfin for neovascular age-related macular degeneration,” The New England Journal of Medicine, vol. 355, no. 14, pp. 1432–1444, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. J. Rosenfeld, D. M. Brown, J. S. Heier et al., “Ranibizumab for neovascular age-related macular degeneration,” The New England Journal of Medicine, vol. 355, no. 14, pp. 1419–1431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. F. Martin, M. G. Maguire, G.-S. Ying, J. E. Grunwald, S. L. Fine, and G. J. Jaffe, “Ranibizumab and bevacizumab for neovascular age-related macular degeneration,” The New England Journal of Medicine, vol. 364, no. 20, pp. 1897–1908, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. F. Martin, M. G. Maguire, S. L. Fine et al., “Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results,” Ophthalmology, vol. 119, no. 7, pp. 1388–1398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Binder, “Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?” British Journal of Ophthalmology, vol. 96, no. 1, pp. 1–2, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. M. W. Stewart and F. J. Rosenfeld, “Predicted biological activity of intravitreal VEGF trap,” British Journal of Ophthalmology, vol. 92, no. 5, pp. 667–668, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. S. Heier, D. M. Brown, V. Chong et al., “Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration,” Ophthalmology, vol. 119, no. 12, pp. 2537–2548, 2012. View at Google Scholar
  8. H. Cho, C. P. Shah, M. Weber, and J. S. Heier, “Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab,” British Journal of Ophthalmology, vol. 97, no. 8, pp. 1032–1035, 2013. View at Google Scholar
  9. B. Bakall, J. C. Folk, H. C. Boldt et al., “Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab,” American Journal of Ophthalmology, vol. 156, no. 1, pp. 15–22, 2013. View at Google Scholar
  10. Y. Yonekawa, C. Andreoli, J. B. Miller et al., “Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration,” American Journal of Ophthalmology, vol. 156, no. 1, pp. 29–35, 2013. View at Google Scholar
  11. F. M. Heussen, Q. Shao, Y. Ouyang, A. M. Joussen, and B. Müller, “Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration,” Graefe's Archive for Clinical and Experimental Ophthalmology, 2013. View at Publisher · View at Google Scholar
  12. V. Y. Ho, S. Yeh, T. W. Olsen et al., “Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors,” American Journal of Ophthalmology, vol. 156, no. 1, pp. 23–28, 2013. View at Google Scholar
  13. C. C. Wykoff, D. M. Brown, M. E. Maldonado, and D. E. Croft, “Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial),” British Journal of Ophthalmology, 2014. View at Publisher · View at Google Scholar
  14. N. Kumar, M. Marsiglia, S. Mrejen et al., “Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration,” Retina, vol. 33, no. 8, pp. 1605–1612, 2013. View at Google Scholar
  15. A. A. Chang, H. Li, G. K. Broadhead et al., “Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration,” Ophthalmology, vol. 121, no. 1, pp. 188–192, 2014. View at Google Scholar
  16. O. S. Punjabi, J. Huang, L. Rodriguez, A. T. Lyon, L. M. Jampol, and R. G. Mirza, “Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy,” British Journal of Ophthalmology, vol. 97, no. 8, pp. 1024–1031, 2013. View at Google Scholar
  17. T. Yamazaki, H. Koizumi, T. Yamagishi, and S. Kinoshita, “Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results,” Ophthalmology, vol. 199, no. 8, pp. 1621–1627, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Schraermeyer and S. Julien, “Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes,” Expert Opinion on Biological Therapy, vol. 13, no. 2, pp. 156–167, 2013. View at Google Scholar
  19. U. Schraermeyer and S. Julien, “Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye,” Graefe’s Archive for Clinical and Experimental Ophthalmology, vol. 250, no. 9, pp. 1303–1313, 2012. View at Google Scholar
  20. S. Julien, A. Biesemeier, T. Taubitz, and U. Schraermeyer, “Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes,” British Journal of Ophthalmology, 2014. View at Publisher · View at Google Scholar